Elevated IL-6 and IL-10 Levels as Prognostic Biomarkers in COVID-19 Pneumonia: A Comparative Study in Mexican Patients
Elevated levels of both IL-6 and IL-10 are a differential risk factor for developing COVID-19 pneumonia. These elevated levels were more frequently observed in Mexican COVID-19 pneumonia patients who died at the onset of the COVID-19 pandemic. It is important that they are monitored from initial diagnosis as they may be markers of a fatal outcome in severe and critical COVID-19 patients.
Authors
- Sandra Pinto-Cardoso (ORCID: https://orcid.org/0000-0001-8957-4972)
- Miguel A. Cortes-Vazquez
- Yessica Sara Pérez-González
- Juan Carlos Núñez-Enríquez (ORCID: https://orcid.org/0000-0002-8070-9727)
- David Eduardo Meza-Sánchez (ORCID: https://orcid.org/0000-0003-0392-296X)
- Charmina Aguirre-Alvarado (ORCID: https://orcid.org/0000-0003-1495-0245)
- Vilma Carolina Bekker‐Méndez (ORCID: https://orcid.org/0000-0002-6161-1425)
Institutions
- Mexican Social Security Institute (MX)
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- Centro Medico Nacional Siglo XXI (MX)
- Instituto Politécnico Nacional (MX)
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Healthcare
- Published
- 2025-05-26
- DOI
- https://doi.org/10.3390/healthcare13111245
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Instituto Politécnico Nacional